EANS-Adhoc: november AG / Further Extraordinary Income Generated By Extensive Debt Waiver / Long-term Repayment

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.


november AG (ISIN: DE000A0S9N72) announces the successful negotiation with another major shareholder, resulting in a debt waiver and reorganization of liabilities. Total financial liabilities of the november AG owed to this major shareholder are exempted from interest. Additionally, a long-term deferment, a long-term repayment or partial repayments were agreed upon within the scope of a long-term payment plan. Another loan to PROGEN Biotechnik in the amount of approx. EUR 1.2 mio was paid off with TEUR 200; TEUR 700 were waived and the remaining debt was converted into a long-term and interest-free repayment plan.

Thus, short-term liabilities were reduced considerably by a total of approx. EUR 1.7 mio. This loan waiver results in an extraordinary income of approx. TEUR 700, improving the equity base by this amount.

Also this further constructive cooperation with another major shareholder represents an additional important milestone in the financial stabilization of the november AG and its subsidiaries.

end of announcement euro adhoc

issuer: november AG Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share

stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, Hannover, München
language: English

Digitale Pressemappe: http://www.ots.at/pressemappe/EASY_19995

Rückfragen & Kontakt:

Dr. Dirk Zurek
Tel.: +49 (0) 221 82200 520 10
E-Mail: ir@november.de